We and others have previously reported that n-3 PUFAs, especially EPA, exerted antineuroinflammatory properties in vivo in animal models of Alzheimer’s disease, Parkinson’s disease, and IL-1β induced neuroinflammation [33,34]. This evidence concerns the gene IL1B and Parkinson disease.